Literature DB >> 17661800

Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.

S K Velioğlu1, S Gazioğlu.   

Abstract

BACKGROUND: Valproic acid (VPA) may induce hyperammonemic encephalopathy. On the other hand, seizure-inducing effects of antiepileptic drugs (AEDs) may be a paradoxical reaction or a result of AED-induced encephalopathy (commonly induced by VPA).
METHODS: We present the case of a 19-year-old male who developed acute mental status changes consistent with encephalopathy evolving into repetitive seizures with oral automatisms induced by relatively small doses of VPA.
RESULTS: Although serum hepatic enzymes, such as AST and ALT, were normal, serum ammonia concentration was high, i.e. 70 micromol/l (normal range 9-33 micromol/l). Administration of VPA was discontinued immediately after admission. The patient's condition improved during the second week of hospitalization and ammonium levels returned to normal.
CONCLUSION: In conclusion, although uncommon, a possible induction of non-convulsive status epilepticus by valproate-induced hyperammonemic encephalopathy should be taken into account and properly managed by discontinuation of the drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661800     DOI: 10.1111/j.1600-0404.2006.00793.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

2.  Rapidly cycling encephalopathy from an almost forgotten entity.

Authors:  Lucio Tremolizzo; Alessio Galbussera; Maura Frigo; Paolo Apale; Maurizio Capra; Ildebrando Appollonio; Carlo Ferrarese
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

3.  A reversible cause of coma in epilepsy.

Authors:  Praveen Kesav; Vishnu V Y; Dheeraj Khurana
Journal:  BMJ Case Rep       Date:  2012-12-13

4.  Risk factors and outcome of hyperammonaemia in people with epilepsy.

Authors:  Umesh Vivekananda; Simona Balestrini; Angeliki Vakrinou; Elaine Murphy; Sanjay M Sisodiya
Journal:  J Neurol       Date:  2022-07-30       Impact factor: 6.682

5.  Nonconvulsive status epilepticus in hepatic encephalopathy.

Authors:  Paul Jhun; Hyung Kim
Journal:  West J Emerg Med       Date:  2011-11

6.  Treatment of acute and remote symptomatic seizures.

Authors:  Barbara S Koppel
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.972

7.  Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.

Authors:  Yu-Lung Tseng; Chi-Ren Huang; Chih-Hsiang Lin; Yan-Ting Lu; Cheng-Hsien Lu; Nai-Ching Chen; Chiung-Chih Chang; Wen-Neng Chang; Yao-Chung Chuang
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.